Meijer J, DePierre J W
Department of Biochemistry, Arrhenius Laboratory, University of Stockholm, Sweden.
Chem Biol Interact. 1988;64(3):207-49. doi: 10.1016/0009-2797(88)90100-7.
Epoxide hydrolase activity is recovered in the high-speed supernatant fraction from the liver of all mammals so far examined, including man. For some as yet unexplained reason, the rat has a very low level of this activity, so that cytosolic epoxide hydrolase is generally studied in mice. This enzyme selectively hydrolyzes trans epoxides, thereby complementing the activity of microsomal epoxide hydrolase, for which cis epoxides are better substrates. Cytosolic epoxide hydrolase has been purified to homogeneity from the livers of mice, rabbits and humans. Certain of the physicochemical and enzymatic properties of the mouse enzyme have been thoroughly characterized. Neither the primary amino acid, cDNA nor gene sequences for this protein are yet known, but such characterization is presently in progress. Unlike microsomal epoxide hydrolase and most other enzymes involved in xenobiotic metabolism, cytosolic epoxide hydrolase is not induced by treatment of rodents with substances such as phenobarbital, 2-acetylaminofluorene, trans-stilbene oxide, or butylated hydroxyanisole. The only xenobiotics presently known to induce cytosolic epoxide hydrolase are substances which also cause peroxisome proliferation, e.g., clofibrate, nafenopin and phthalate esters. These and other observations indicate that this enzyme may actually be localized in peroxisomes in vivo and is recovered in the high-speed supernatant because of fragmentation of these fragile organelles during homogenization, i.e., recovery of this enzyme in the cytosolic fraction is an artefact. The functional significance of cytosolic epoxide hydrolase is still largely unknown. In addition to deactivating xenobiotic epoxides to which the organism is exposed directly or which are produced during xenobiotic metabolism, primarily by the cytochrome P-450 system, this enzyme may be involved in cellular defenses against oxidative stress.
迄今为止,在包括人类在内的所有已检测哺乳动物的肝脏高速上清液组分中均可恢复环氧水解酶活性。出于某些尚未明确的原因,大鼠体内该酶的活性水平极低,因此通常在小鼠中研究胞质环氧水解酶。这种酶选择性地水解反式环氧化物,从而补充微粒体环氧水解酶的活性,对于微粒体环氧水解酶而言,顺式环氧化物是更好的底物。胞质环氧水解酶已从小鼠、兔子和人类的肝脏中纯化至均一性。小鼠酶的某些物理化学和酶学特性已得到充分表征。该蛋白质的一级氨基酸序列、cDNA序列和基因序列均未知,但目前正在进行此类表征。与微粒体环氧水解酶和大多数其他参与外源性物质代谢的酶不同,用苯巴比妥、2-乙酰氨基芴、反式氧化茋或丁基羟基茴香醚等物质处理啮齿动物不会诱导胞质环氧水解酶。目前已知的唯一能诱导胞质环氧水解酶的外源性物质是那些也会导致过氧化物酶体增殖的物质,例如氯贝丁酯、萘酚平酯和邻苯二甲酸酯。这些以及其他观察结果表明,这种酶实际上可能在体内定位于过氧化物酶体中,并且由于在匀浆过程中这些脆弱细胞器的破碎而在高速上清液中被回收,即这种酶在胞质组分中的回收是一种假象。胞质环氧水解酶的功能意义仍然很大程度上未知。除了使生物体直接接触的或在外源性物质代谢过程中主要由细胞色素P-450系统产生的外源性环氧化物失活外,这种酶可能还参与细胞对氧化应激的防御。